Capital Investment Advisors, LLC Gilead Sciences, Inc. Transaction History

Capital Investment Advisors, LLC

$4.79 Billion
Q3 2024

A detailed history of Capital Investment Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 377,701 shares of GILD stock, worth $35.5 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

377,701

Previous 340,863 10.81%

Holding current value

$35.5 Million

Previous $23.4 Million 35.37%

% of portfolio

0.66%

Previous 0.53%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$66.59 - $83.99 $2.45 Million - $3.09 Million	36,838 Added 10.81%	377,701 $31.7 Million
Q2 2024 Jul 12, 2024	BUY	$63.15 - $72.88 $644,824 - $744,177	10,211 Added 3.09%	340,863 $23.4 Million
Q1 2024 Apr 15, 2024	SELL	$71.58 - $87.29 $588,029 - $717,087	-8,215 Reduced 2.42%	330,652 $24.2 Million
Q4 2023 Jan 05, 2024	BUY	$73.27 - $83.09 $613,782 - $696,044	8,377 Added 2.53%	338,867 $27.5 Million
Q3 2023 Oct 16, 2023	BUY	$73.94 - $80.67 $1.85 Million - $2.02 Million	25,022 Added 8.19%	330,490 $24.8 Million
Q2 2023 Jul 11, 2023	BUY	$76.01 - $86.7 $1.22 Million - $1.39 Million	16,050 Added 5.55%	305,468 $23.5 Million
Q1 2023 Apr 10, 2023	SELL	$77.31 - $88.08 $774,878 - $882,825	-10,023 Reduced 3.35%	289,418 $24 Million
Q4 2022 Jan 05, 2023	BUY	$62.32 - $89.47 $817,513 - $1.17 Million	13,118 Added 4.58%	299,441 $25.7 Million
Q3 2022 Oct 05, 2022	BUY	$59.54 - $68.01 $1.32 Million - $1.51 Million	22,213 Added 8.41%	286,323 $17.7 Million
Q2 2022 Jul 06, 2022	BUY	$57.72 - $65.01 $1.25 Million - $1.41 Million	21,732 Added 8.97%	264,110 $16.3 Million
Q1 2022 Apr 13, 2022	SELL	$57.92 - $72.58 $364,027 - $456,165	-6,285 Reduced 2.53%	242,378 $14.4 Million
Q4 2021 Jan 10, 2022	BUY	$64.88 - $73.64 $455,652 - $517,173	7,023 Added 2.91%	248,663 $18.1 Million
Q3 2021 Oct 13, 2021	BUY	$67.69 - $73.03 $1.41 Million - $1.52 Million	20,818 Added 9.43%	241,640 $16.9 Million
Q2 2021 Jul 14, 2021	BUY	$63.47 - $69.35 $798,896 - $872,908	12,587 Added 6.04%	220,822 $15.2 Million
Q1 2021 Apr 27, 2021	BUY	$60.0 - $68.46 $719,100 - $820,493	11,985 Added 6.11%	208,235 $13.5 Million
Q4 2020 Jan 21, 2021	BUY	$56.65 - $64.55 $210,738 - $240,126	3,720 Added 1.93%	196,250 $11.4 Million
Q3 2020 Oct 29, 2020	BUY	$62.1 - $78.08 $10.6 Million - $13.3 Million	170,334 Added 767.41%	192,530 $12.2 Million
Q2 2020 Jul 20, 2020	BUY	$72.34 - $84.0 $589,064 - $684,012	8,143 Added 57.94%	22,196 $1.71 Million
Q1 2020 Apr 13, 2020	SELL	$62.63 - $80.22 $38,392 - $49,174	-613 Reduced 4.18%	14,053 $1.05 Million
Q4 2019 Jan 21, 2020	SELL	$61.62 - $67.78 $73,697 - $81,064	-1,196 Reduced 7.54%	14,666 $953,000
Q3 2019 Oct 24, 2019	SELL	$62.51 - $69.0 $18,440 - $20,355	-295 Reduced 1.83%	15,862 $1.01 Million
Q2 2019 Jul 17, 2019	SELL	$61.87 - $69.38 $456,291 - $511,677	-7,375 Reduced 31.34%	16,157 $1.09 Million
Q1 2019 Apr 11, 2019	SELL	$62.53 - $70.05 $294,828 - $330,285	-4,715 Reduced 16.69%	23,532 $1.53 Million
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $184,525 - $240,792	-3,048 Reduced 9.74%	28,247 $1.77 Million
Q3 2018 Oct 15, 2018	SELL	$71.28 - $78.92 $94,802 - $104,963	-1,330 Reduced 4.08%	31,295 $2.42 Million
Q2 2018 Jul 10, 2018	SELL	$64.88 - $75.68 $14,273 - $16,649	-220 Reduced 0.67%	32,625 $2.31 Million
Q1 2018 Apr 16, 2018	BUY	$72.84 - $88.8 $49,531 - $60,384	680 Added 2.11%	32,845 $2.48 Million
Q4 2017 Jan 17, 2018	BUY	$71.15 - $83.52 $4,695 - $5,512	66 Added 0.21%	32,165 $2.3 Million
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $2.31 Million - $2.74 Million	32,099	32,099 $2.6 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.

Account

Capital Investment Advisors, LLC Gilead Sciences, Inc. Transaction History